Pharmacodynamics and Outcomes of a De-Escalation Strategy with Half-Dose Prasugrel or Ticagrelor in East Asians Patients with Acute Coronary Syndrome: Results from HOPE-TAILOR Trial

East Asians treated with potent P2Y12 inhibitors (prasugrel or ticagrelor) generally experience more intense platelet inhibitory responses resulting in an increased risk of major bleeding. Whether a half-dose de-escalation strategy improves the net clinical benefit in Korean patients with acute coro...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Cai-De, Kim, Moo-Hyun, Song, Kai, Jin, Xuan, Lee, Kwang-Min, Park, Jong-Sung, Cho, Young-Rak, Yun, Sung-Cheol, Lee, Michael S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234416/
https://www.ncbi.nlm.nih.gov/pubmed/34207339
http://dx.doi.org/10.3390/jcm10122699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234416/
https://www.ncbi.nlm.nih.gov/pubmed/34207339
http://dx.doi.org/10.3390/jcm10122699

Ejemplares similares